Early research (Phase 1)Ended earlyNCT03735290
What this trial is testing
Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer
Who this might be right for
Carcinoma, Squamous Cell of Head and NeckGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more
Mendus 21